Navigation Links
ENT and Allergy Associates Merges with Hudson Valley ENT, Adds Five Superb Physicians, Expands Overall County Presence

Tarrytown, NY (PRWEB) June 18, 2013

ENT and Allergy Associates, LLP (ENTA) does not expand simply to grow in size. Quite the opposite.

New York/New Jersey’s premier ear, nose, throat, allergy and audiology practice-with over 140 expertly trained physicians offering superior healthcare to children and adults in hundreds of communities in 40 locations throughout the Greater New York area-only considers adding to its current footprint when all the important circumstances are right. And that includes the right communities to serve, the right locations from which to serve, and the absolutely right ENTS, Allergists and Audiologists with which to serve. It is rare when these conditions coalesce.

But that’s exactly what has taken place in Orange County, NY, where ENTA today announced a merger with the well-known and well respected Hudson Valley Ear, Nose and Throat practice, effective October 1st, 2013. With this merger, the existing Hudson Valley ENT Middletown location, at 75 Crystal Run Rd., Bldg. B, Suite 220, Middletown, NY 10941, will become an office of ENTA. Hudson Valley’s Newburgh office (currently at 1200 Stony Brook Court, Newburgh, NY 12550) will close and become part of ENTA’s state-of-the-art New Windsor site, at 103 Executive Drive, 3rd Floor, Suite 500, New Windsor, NY 12553. As a result, all patients will be able to avail themselves of the full scope of ENTA’s comprehensive and integrated approach to leading edge medical care, an opportunity they simply cannot and will not receive anywhere else.

In the near future, ENTA will be recruiting an additional ENT and Allergist at the new Middletown office.

Wayne Eisman, MD, President of ENT and Allergy Associates, noted that “Our group will continue to explore expansion opportunities as long as they are consistent with our long term strategy of highest quality physicians committed to providing clinical excellence”.

The entire existing roster of superb clinicians will be joining ENTA, including partners Ofer Jacobowitz, MD, PhD, FAASM, FAAOA; Mark S. Driver, MD; Phillip L. Massengill, MD, FACS; Sergey Koyfman, DO; and Virginia E. Feldman, MD. Each is Board Certified in Otolaryngology and skilled in all aspects of ENT including Otology, Head and Neck surgery, Sinus Surgery, Pediatric Otolaryngology, Laryngology, and Sleep Medicine.

Ofer Jacobowitz, MD, PhD, FAASM, FAAOA is a nationally and internationally recognized expert in obstructive sleep apnea. He graduated from the Massachusetts Institute of Technology with a Bachelor of Sciences degree in life sciences. He continued his studies at the medical scientist training program of the Mount Sinai School of Medicine and graduated with a Ph.D. in Pharmacology and an MD degree. Dr. Jacobowitz performed his postgraduate training in Otolaryngology / Head and Neck Surgery at Mount Sinai Medical Center where he is currently an assistant clinical professor. He is board certified in otolaryngology/ Head and Neck Surgery, as well as Sleep Medicine, and is a fellow of the American Academy of Sleep Medicine and the American Academy of Otolaryngic Allergy. He is an expert member of the Outcome Measures Task Force for Adult OSA of the American Academy of Sleep Medicine and has served as Chair of the sleep-related breathing disorders section and all membership sections from 2012 to 2013. Dr. Jacobowitz is the recipient of the honor award of the American Academy of Otolaryngology Head and Neck Surgery where he is also a member of the Sleep Disorders and the Medical Devices Committees. Dr. Jacobowitz has published extensively in the field of sleep apnea and is a peer reviewer for scientific journals. He specializes in the medical and surgical treatment of snoring and sleep apnea for adults and children, as well as sinusitis, nasal obstruction, thyroid cancer, head and neck cancer. He will be seeing patients in the Middletown and 5th Avenue offices.

Mark S. Driver, MD graduated from Wright State University in 2000. He completed his Internship in General Surgery at Boston University School of Medicine as well as his Residency at the Department of Otolaryngology-Head and Neck Surgery. His areas of expertise are Pediatric and Adult Ear, Nose and Throat, Endoscopic Sinus Surgery, ENT Allergy, Laryngology Voice Disorders and Head and Neck Cancer Surgery.

Phillip L. Massengill, MD, FACS graduated from Boston University School of Medicine in 1995. He completed his Surgical Internship at Walter Reed Army Medical Center in Washington, DC. He then went on to do residency in the Department of Otolaryngology—Head and Neck Surgery at Madigan Army Medical Center in Tacoma, Washington, in conjunction with the Department of Otolaryngology—Head and Neck Surgery at the University of Washington in Seattle. He became Chief Resident of the Otolaryngology—Head and Neck Surgery Department in 2001 through 2002. Dr. Massengill is a military veteran serving as a Physician in the United States Army from 1995-2006.

Sergey Koyfman, DO graduated from New York College of Osteopathic Medicine in 2001. He completed his Surgical Osteopathic/Otolaryngology Internship at Michigan State University and went on to complete his Residency in Otolaryngology and Facial Plastic Surgery there from 2002 through 2006. In 2007, he completed one year of fellowship in Head and Neck Oncology and Micro-Vascular Reconstructive Surgery at Indiana University School of Medicine. Dr. Koyfman is Board Certified by the American Osteopathic Association and is certified in both Otolaryngology and Facial Plastic Surgery. Dr. Koyfman is the Medical Director of the Head and Neck Oncology Program, Orange Regional Medical Center and Assistant Clinical Professor of Otolaryngology/ Head and Neck Surgery Mount Sinai Hospital/ School of Medicine.

Virginia E. Feldman, MD graduated from New York Medical College in 1991. She completed residency in General Surgery at St. Vincent's Hospital and Medical Center of New York and a residency in Otolaryngology at The New York Eye and Ear Infirmary. Dr. Feldman is the Managing Partner of Hudson Valley Ear, Nose & Throat, P.C. as well as the Managing Partner of Hudson Valley Ambulatory Surgery, LLC. Her areas of expertise include Pediatric and Adult Ear, Nose and Throat, which include Balance Disorders and Hearing Loss, Otitis Media, Tonsil and Adenoid Disease, Sinus and Allergy Disease.

All of these physicians will continue to be affiliated with the Orange Regional Medical Center, Columbia/New York Presbyterian Hospital, and the Mount Sinai Hospital.

Hudson Valley ENT has been serving the Hudson Valley community for more than 10 years, and their existing location-located at 75 Crystal Run Road, Building B, Suite 220, Middletown, NY 10941 will become the second clinical office location in Orange County and the 40th clinical office location for ENT and Allergy overall.

"We have been providing compassionate, professional Ear, Nose and Throat care to Hudson Valley residents for over ten years, said Dr. Virginia Feldman, managing partner of Hudson Valley ENT. We are confident that joining a practice of ENTA’s reputation and scope provides us with the resources to continue to offer our patients and the Hudson Valley community the quality and breadth of medical services they deserve and have come to depend on from us."

Robert Glazer, CEO of ENTA added, “Hudson Valley’s sterling reputation speaks for itself. These five fine physicians have earned the respect, trust, and loyalty of the communities they have long served in Middletown, and made them the perfect fit for ENTA. Our goal is to ensure that the finest medical care possible is available to our patient base, and merging with Hudson Valley makes this a reality for the people of Orange County.”

To learn even more about the benefits of ENT and Allergy Associates, please visit, where patients can conveniently find an ENT doctor or find an Allergy Doctor, and then easily book an appointment at the nearest New York (NY) or New Jersey (NJ) location.

ENTA has over 140 physicians in 40 office locations in Westchester, Putnam, Orange, Dutchess, Rockland, Nassau and Suffolk counties, New York City, Long Island, northern New Jersey and 3 offices in central New Jersey. Each ENTA clinical location provides access to a full complement of services, including General Adult and Pediatric ENT, Voice and Swallowing, Facial Plastics and Reconstructive Surgery, Disorders of the Inner Ear and Dizziness, Asthma, Clinical Immunology, Diagnostic Audiology, Hearing Aid dispensing, Sleep and CT Services. ENTA has a clinical alliance with The Mount Sinai Hospital for the treatment of diseases of the head and neck and esophageal cancer and a partnership with the American Cancer Society to educate and treat patients with smoking disorders and cancer. ENTA has also expanded its clinical capabilities to include advanced Immunodeficiency trials. Visit for more information.

Read the full story at

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. David H. Koch donates $10 million to Mount Sinais Jaffe Food Allergy Institute
2. Study Ties Kids Allergy Risks to Antibacterials, Preservatives
3. New £340,000 investment into asthma and allergy research at University of Leicester
4. Allergy-like symptoms after drinking wine
5. Certain Tick Bites Might Spur Red Meat Allergy
6. Mechanism found for destruction of key allergy-inducing complexes, Stanford researchers say
7. New target discovered for food allergy treatment
8. The year 2040: Double the pollen, double the allergy suffering?
9. The Internet becomes next Nostradamus for allergy season
10. Socioeconomic status linked to childhood peanut allergy
11. Lone Star Tick Bite Might Trigger Red Meat Allergy: Study
Post Your Comments:
(Date:10/10/2015)... York, NY (PRWEB) , ... October 10, 2015 , ... ... some alarming numbers on the growth of cybercrime costs for US companies. The New ... on Tuesday, October 6th. With averages showing increases hovering around 20% among the companies ...
(Date:10/10/2015)... , ... October 10, 2015 , ... Isabel Healthcare will ... , On the heels of the release of the Institute of Medicine’s latest report ... their integration with Cerner solutions that assist healthcare providers and consumers to potentially reduce ...
(Date:10/9/2015)... ... October 09, 2015 , ... The American Osteopathic ... for Graduate Medical Education J. Michael Finley, DO, as the recipient of the ... for his impact on graduate medical education opportunities for osteopathic residents, and his ...
(Date:10/9/2015)... ... 2015 , ... A new health tool that helps identify if a sore ... ) – just in time for the cold and flu season, which the ... many in the U.S., the real start of cold/flu season is the start of ...
(Date:10/9/2015)... ... October 09, 2015 , ... Dentist in Huntington ... orthodontic system that uses clear, plastic aligners. This alternative to braces has become ... which allow patients to complete treatment in privacy. Additionally, Invisalign aligners are removable, ...
Breaking Medicine News(10 mins):
... serious problem that can often be fatal. Methadone has ... addicts. However, the major concern in treating heroin addicts ... is one reason methadone therapy is usually only given ... that an alternative drug therapy combined with psychosocial treatment ...
... researchers are currently testing the safety of hypothermia ... injury. Hypothermia treatment has been shown to be ... but its effectiveness in treating children with traumatic ... decreases inflammation, excitotoxicity (excessive neurotransmitters released with injury ...
... of skin cancer and it has been shown through previous ... sunlight, whose UV rays cause damage to DNA that triggers ... are more prone than others to melanoma. Researchers have now ... people with melanoma that those with fair skin// have lowered ...
... Affective Disorder(SAD) is not all that well understood, but ... sunlight in the winter months. Winter depression involves suffering ... days get longer and nights get shorter. Other SAD ... sleeping for longer than usual. Researchers have now found ...
... hospital in Kolkatta, India recently received a patient, a two-month-old ... suffering from a rare disease caused due to a deficiency ... of 10 million children. Doctors said that the baby was ... On detection the baby, a boy child, was found to ...
... time to its ultraviolet rays, has always been said to be ... shown that even moderate sun exposure can result in moles that ... to sun has been shown as the main risk factor for ... rarest type of skin cancer, is much weaker. It has however, ...
Cached Medicine News:
(Date:10/8/2015)... Oct. 8, 2015  Clariant, a world leader in specialty ... facility in Belen, New Mexico , has ... including desiccant canisters and packets and other ... plant is the second Clariant site – the first in ... the ISO 15378:2011 standards, following only the Clariant manufacturing facility ...
(Date:10/8/2015)... , Oct. 8, 2015  Nektar Therapeutics (Nasdaq: ... pain and oncology portfolio during an Investor and Analyst ... p.m. Eastern Time in New York City ... of the NKTR-214 Phase 1/2 clinical program and biomarker ... cytokine designed to preferentially stimulate the production of CD8-positive ...
(Date:10/8/2015)... a clinical stage drug development company focused on advancing ... today the commencement of the US arm of an ... acebilustat, in patients with cystic fibrosis (CF). The study ... the United States and European Union, ... 2016. This landmark clinical trial testing once-daily oral acebilustat ...
Breaking Medicine Technology:
... Texas, Dec. 2, 2010 Ascension Orthopedics, Inc., ... another implantation of the TITAN™ Modular Total Shoulder. ... at Bucks County Specialty Hospital in Bensalem, Pennsylvania. ... postoperative x-rays showed a very anatomic replacement.  The ...
... 2, 2010 Medical devices, biotechnology and IT products ... will present to United States investors and the business ... business and investment opportunities. (Logo: ... successful Chilean Small and Medium Enterprises (SMEs) was selected ...
Cached Medicine Technology:
The IRN method used on the Dimension clinical chemistry system is an in vitro diagnostic test intended for the quantitative determination of iron in serum....
For the quantitative in vitro determination of Aspartate Aminotransferase (AST) in serum and plasma....
Enzymatic Clearance assay for the in vitro quantitative determination of HDL-cholesterol in human serum and plasma....
Immunoturbidimetric assay for the quantitative in vitro determination of Lipoprotein (a) in human serum or plasma...
Medicine Products: